Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.62B
Enterprise Value2.99B
P/E Ratio-15.12
PEG Ratio0.9
Price/Sales Ratio6.81
Price/Book Ratio1.44
Enterprise/Revenue6.57
Enterprise/EBITDA-17.87

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.44
Operating Margin-0.48
AD

Management Effectiveness

Return On Assets-0.08
Return On Equity-0.09

Income Statement

Revenue541.45M
Revenue/Share3.31
Gross Profit230.88M
EBITDA-140.03M
Net Income-231.27M
Diluted EPS-1.77

Balance Sheet

Total Cash433.7M
Total Cash/Share3.31
Total Debt34.41M
Total Debt/Equity0.02
Current Ratio4.43
Book Value Per Share15.65

Price History

52-Week Change-33.5
52-Week High50.68
52-Week Low21.15
Moving Average 50 Days24.13
Moving Average 200 Days29.33

Statistics

Average Volume6.45M
Shares Outstanding130.89M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.01
Last Split FactorN/A
Last Split DateN/A
AD